Inside Drug Pricing - 11/04/2019

Grassley Sees No Reason To Drop Inflation Rebates From Rx Pricing Bill

By John Wilkerson / November 1, 2019 at 1:24 PM
Senate Finance Committee Chair Chuck Grassley doesn’t plan to drop inflationary rebates from the drug pricing bill he and ranking committee Democrat Ron Wyden (OR) wrote, a spokesperson for the Iowa Republican said, even though White House Domestic Policy Council chief Joe Grogan reportedly said that measure is now negotiable . Many Republicans consider inflationary rebates to be government price controls, which they oppose, but Grassley has been pushing his party to back the bill with the rebates. The most...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.